盈健醫療(01419.HK):目前正與Heals Healthcare就業務聯盟協議和認購協議的修訂進行商議
格隆匯4月9日丨盈健醫療(01419.HK)公佈,監於2019年下半年香港的社會運動以及2020年1月下旬新型冠狀病毒在香港爆發,初始功能的建設和開發特別是涉及現有及潛在客户的測試過程被受影響,並沒有按業務聯盟協議的條款完全完成。公司目前正與Heals Healthcare (Asia) Limited(前稱Heals Healthcare Limited)("目標公司")就業務聯盟協議和認購協議的修訂進行商議,包括延長原定自業務聯盟協議日起計12個月的延長準備期和重新編排初始關鍵績效指標計算期。由於上述的延期,於公告日期,認購協議項下的初始關鍵績效指標計算期將重新編排,而配發第二批認購股份及第三批認購股份的先決條件亦尚未達成。此外,於公告日期,集團並未簽訂任何具法律約束力的協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.